Shazli N. Malik

1.5k total citations
16 papers, 1.2k citations indexed

About

Shazli N. Malik is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shazli N. Malik has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Shazli N. Malik's work include PI3K/AKT/mTOR signaling in cancer (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Shazli N. Malik is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Shazli N. Malik collaborates with scholars based in United States, Switzerland and Mexico. Shazli N. Malik's co-authors include Jeffrey I. Kreisberg, Roble Bedolla, P. Ghosh, Dean A. Troyer, Thomas J. Prihoda, Michael G. Brattain, Abhik Bandyopadhyay, Fernando López‐Casillas, William M. Murphy and Junhua Yang and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Shazli N. Malik

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shazli N. Malik United States	13	801	411	400	232	147	16	1.2k
Fraser Symmans United States	14	596 0.7×	597 1.5×	317 0.8×	290 1.3×	124 0.8×	21	1.2k
Morag Seywright United Kingdom	17	481 0.6×	322 0.8×	311 0.8×	242 1.0×	92 0.6×	40	948
Wenhua Lang United States	17	784 1.0×	374 0.9×	304 0.8×	257 1.1×	91 0.6×	28	1.3k
Michio Sugita Japan	12	810 1.0×	561 1.4×	358 0.9×	389 1.7×	115 0.8×	32	1.3k
Yuji Basaki Japan	20	1.1k 1.3×	540 1.3×	295 0.7×	214 0.9×	218 1.5×	27	1.5k
Do-Sun Byun United States	11	1.3k 1.6×	614 1.5×	242 0.6×	229 1.0×	189 1.3×	11	1.7k
Chundong Gu China	20	535 0.7×	299 0.7×	357 0.9×	238 1.0×	97 0.7×	51	1.0k
Qi-Shan Dai China	21	770 1.0×	289 0.7×	291 0.7×	426 1.8×	78 0.5×	39	1.2k
Kun-Tu Yeh Taiwan	23	866 1.1×	438 1.1×	184 0.5×	346 1.5×	108 0.7×	43	1.4k
Il-Jin Kim United States	21	942 1.2×	535 1.3×	176 0.4×	254 1.1×	202 1.4×	54	1.4k

Countries citing papers authored by Shazli N. Malik

Since Specialization

Citations

This map shows the geographic impact of Shazli N. Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shazli N. Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shazli N. Malik more than expected).

Fields of papers citing papers by Shazli N. Malik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shazli N. Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shazli N. Malik. The network helps show where Shazli N. Malik may publish in the future.

Co-authorship network of co-authors of Shazli N. Malik

This figure shows the co-authorship network connecting the top 25 collaborators of Shazli N. Malik. A scholar is included among the top collaborators of Shazli N. Malik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shazli N. Malik. Shazli N. Malik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Malik, Shazli N., et al.. (2021). Primary pancreatic cancer of the jejunum: a case report and brief review of literature. Journal of Surgical Case Reports. 2021(10). rjab469–rjab469. 1 indexed citations

Bedolla, Roble, Thomas J. Prihoda, Jeffrey I. Kreisberg, et al.. (2007). Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation. Clinical Cancer Research. 13(13). 3860–3867. 115 indexed citations

Kreisberg, Jeffrey I., Shazli N. Malik, Thomas J. Prihoda, et al.. (2004). Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer. Cancer Research. 64(15). 5232–5236. 262 indexed citations

Tolcher, Anthony W., John G. Kuhn, Garry Schwartz, et al.. (2004). A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the Bcl-2 mRNA, and of Docetaxel in Patients with Hormone-Refractory Prostate Cancer. Clinical Cancer Research. 10(15). 5048–5057. 61 indexed citations

DeArmond, Daniel T., Michael G. Brattain, J. Milburn Jessup, et al.. (2003). Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene. 22(49). 7781–7795. 51 indexed citations

Malik, Shazli N., Roble Bedolla, Manuel Hidalgo, Michael G. Brattain, & Jeffrey I. Kreisberg. (2003). Immunohistochemical Determination of EGFR-Tyrosine Kinase Inhibition in Clinical Samples. Humana Press eBooks. 85. 135–140. 6 indexed citations

Ghosh, P., Shazli N. Malik, Roble Bedolla, & Jeffrey I. Kreisberg. (2003). Akt in Prostate Cancer: Possible Role in Androgen-Independence. Current Drug Metabolism. 4(6). 487–496. 69 indexed citations

Malik, Shazli N., Lillian L. Siu, Eric K. Rowinsky, et al.. (2003). Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.. PubMed. 9(7). 2478–86. 104 indexed citations

Bandyopadhyay, Abhik, Yong Zhu, Shazli N. Malik, et al.. (2002). Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Oncogene. 21(22). 3541–3551. 69 indexed citations

10.

Malik, Shazli N., Michael G. Brattain, P. Ghosh, et al.. (2002). Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.. PubMed. 8(4). 1168–71. 264 indexed citations

11.

Bandyopadhyay, Abhik, Fernando López‐Casillas, Shazli N. Malik, et al.. (2002). Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.. PubMed. 62(16). 4690–5. 114 indexed citations

12.

Malik, Shazli N., et al.. (2001). Benign Cellular Changes in Pap Smears. Acta Cytologica. 45(1). 5–8. 12 indexed citations

13.

Malik, Shazli N. & William M. Murphy. (1999). Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice. Urology. 54(1). 62–66. 34 indexed citations

14.

Malik, Shazli N., et al.. (1999). Do Qualifiers of ASCUS Distinguish Between Low- and High-Risk Patients?. Acta Cytologica. 43(3). 376–380. 41 indexed citations

15.

Malik, Shazli N. & Edward J. Wilkinson. (1999). Pseudo-Paget's Disease of the Vulva: A Case Report. Journal of Lower Genital Tract Disease. 3(3). 201–203. 4 indexed citations

16.

Boockvar, John A., Karen Black, Shazli N. Malik, Albert Stanek, & Kevin J. Tracey. (1997). Subacute Paraparesis Induced by Venous Thrombosis of a Spinal Angiolipoma. Spine. 22(19). 2304–2308. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact